Back

Efficacy of digitoxin according to left ventricular ejection fraction in DIGIT-HF

28 August 2026 (14:03 - 14:21)
Organised by: Logo
Congress Presentation Part of: Therapy for HFrEF: improving outcomes in the real world Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Udo Bavendiek

Hannover Medical School, Hannover (Germany)

3 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on contemporary therapy for HFrEF
Professor J. Bauersachs (Hannover, DE)
Video
Presentation thumbnail
Lipid-lowering therapy and cause-specific mortality in incident heart failure: A nationwide register study
Doctor A. Berg (Gothenburg, SE)
Abstract Video
Presentation thumbnail
Vericiguat outcomes by pre-randomisation worsening heart failure events: a post-hoc recurrent events analysis of the VICTOR trial
Professor S. Stoerk (Wuerzburg, DE)
Abstract Video

Access the full session

Session thumbnail
Therapy for HFrEF: improving outcomes in the real world
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 14:03 CET
You may be interested in
thumbnail
Congress Presentation
DIGIT-HF: Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
29 August 2025
thumbnail
Congress Presentation
Discussant review - DECISION/DIGIT-HF/DIG Meta Analysis
10 May 2026
thumbnail
Congress Presentation
Digoxin improves systolic cardiac function in patients with AF and HFpEF: the RATE-AF randomised trial
29 August 2022
thumbnail
Congress Presentation
Top 10 Papers 2025 in heart failure, cardio-oncology, and cardiovascular imaging - discussion
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources